462

Devang Mehta, Anand Rathi Financial Services is of the view that investor can hold Cipla with a target of Rs 462. Mehta told CNBC-TV18 the pricing policy ( more details ) was overall fair to neutral for the pharma sector and may not have impact on Cipla as such. However, he says, Cipla...